2005
DOI: 10.1128/iai.73.11.7789.2005
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Opsonic and Protective Activities of Staphylococcus aureus Conjugate Vaccines Containing Native or Deacetylated Staphylococcal Poly- N -Acetyl-β-(1-6)-Glucosamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
81
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 46 publications
(84 citation statements)
references
References 0 publications
3
81
0
Order By: Relevance
“…Most normal (i.e., nonimmunized) human or animal sera have little to no natural antibodies that mediate opsonic killing of S. aureus (17)(18)(19), a process that also requires a significant contribution from complement (20,21), which was determined to be present at ∼5% of serum levels in the abscesses of infected mice. We thus hypothesized that control of this microbe within abscesses possibly could be due to a secreted antimicrobial factor.…”
Section: Resultsmentioning
confidence: 99%
“…Most normal (i.e., nonimmunized) human or animal sera have little to no natural antibodies that mediate opsonic killing of S. aureus (17)(18)(19), a process that also requires a significant contribution from complement (20,21), which was determined to be present at ∼5% of serum levels in the abscesses of infected mice. We thus hypothesized that control of this microbe within abscesses possibly could be due to a secreted antimicrobial factor.…”
Section: Resultsmentioning
confidence: 99%
“…Opsonophagocytic Killing Assay-An opsonophagocytic killing assay was performed with modifications as described previously (35,36). S. aureus strains were grown to the logarithmic phase (A 578 ϭ 0.5) in LB medium and diluted in RPMI medium containing 0.05% human serum albumin.…”
Section: Methodsmentioning
confidence: 99%
“…Immunisation with either highly acetylated (>95%) or poorly acetylated ( 15%) PIA conjugated to diphtheria toxoid showed in-vitro opsonic killing of both S. aureus and S. epidermidis (Maira-Litrán et al 2005). Protection was due to antibodies directed against the non-acetylated PIA antigen (Maira-Litrán et al 2005). A monoclonal antibody against staphylococcal lipotechoic acids has been developed by Biosynexus Inc.…”
Section: Novel Prophylactic Approachesmentioning
confidence: 99%